The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...

Discover today's top financial insights! From 23andMe's downfall to SPAC risks, market updates, and more. Stay ahead with ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

But since 23andMe is not a medical provider it does not have to abide by standard privacy policies that must be followed at a doctor's office. Such services are "not regulated well," said Ayday.

Detailed price information for 23Andme Holding Co. (ME-Q) from The Globe and Mail including charting and trades.

The genetic testing company 23andMe has filed for bankruptcy, prompting people who’ve used the service and sent in DNA samples to be analyzed to wonder what will happen to their genetic data.

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...